NCT01948791
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- Novartis Investigative Site Beijing, China
Clinical trial condition
Alzheimer Disease
Explore clinical trials studying Alzheimer Disease. Study availability and eligibility vary by location and protocol.
2,958 public trials
523 recruiting studies
Alzheimer Disease trial results
NCT02546310
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- Neuroscience and Psychiatry Unit Manchester, United Kingdom
Completed
Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults
NCT02051335
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +13 more
- Locations
-
- London, United Kingdom
NCT01231295
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- CHU d'Amiens - Hôpital Sud Amiens, France
- CHU d'Angers - Hôtel-Dieu Angers, France
- CHU de Besançon - Hôpital Jean Minjoz Besançon, France
- CHU de Bordeaux - Groupe Hospitalier Pellegrin Bordeaux, France
NCT03034746
- Conditions
- Alzheimer Disease, Behavior, Brain Diseases, +12 more
- Locations
-
Not specified
NCT00580931
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- UC Irvine School of Medicine Irvine, California, United States
Completed
ABILITY - TelerehABILITation: TechnologY-enhanced Multi-domain at Home Continuum of Care Program
NCT02746484
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +9 more
- Locations
-
Not specified
NCT02648672
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- Jasper Clinic Kalamazoo, Michigan, United States
Completed
A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects
NCT02840279
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- Jasper Clinic Kalamazoo, Michigan, United States
Completed
Absolute Bioavailability of a Single, Fixed Subcutaneous Dose of Aducanumab in Healthy Participants
NCT02782975
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
- Locations
-
- Research Site Evansville, Indiana, United States
- Research Site Dallas, Texas, United States